OpenVSafe by OpenVAERS
Search V-safe

3KZ-17038-19388

3 vaccinations 3 coded responses 16 check-ins 2 free-text entries 3 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
781 / TX
Registered
2021-01-14
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-13
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-14
    Registered in v-safe
  3. 2021-01-15
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lacrimation increased — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Eyes watering
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-15
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Muscle or body aches, Fatigue or tiredness, Diarrhea
    Adult check-in
  6. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  7. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-01-22
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-01-27
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-03
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  11. 2021-02-05
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness
    Adult check-in
  13. 2021-02-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-02-12
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-19
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-19
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  17. 2021-05-07
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-08-06
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2022-01-28
    Dose 3 — Pfizer-BioNTech
  20. 2022-07-29
    Survey response — 6 months, dose 3
    MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Pregnant
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-07-29
    Report sent to call center — 6 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  22. 2022-08-01
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  23. 2023-01-30
    Survey response — 12 months, dose 3
    MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  24. 2023-01-30
    Report sent to call center — 12 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  25. 2023-01-31

Vaccinations

DoseDateManufacturerCo-administered
12021-01-13Pfizer-BioNTech
22021-02-05Pfizer-BioNTech
32022-01-28Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-15 priority 2/3
2022-07-29 Successful
2022-08-01
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-01-30 Unsuccessful

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-15

Systemic reaction (other): Eyes watering

Release 12 — 6 months, dose 3

2022-07-29

Symptoms: Pregnant

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDPregnancy · · ✓
SROLacrimation increased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release